Categories: News

Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

LEHI, Utah, Sept. 4, 2025 /PRNewswire/ — Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class anti-inflammatory therapies, today announced that the Company plans to participate in the Morgan Stanley 23rd Annual Global Healthcare Conference.

- Advertisement -

Jared Bearss, Chief Operating Officer of Halia, will provide a business overview presentation on Tuesday, September 9, 2025 at 7:00 am ET.

- Advertisement -

About Halia Therapeutics

- Advertisement -

Halia Therapeutics is a clinical-stage biopharmaceutical company focused on treating the root causes of inflammation. Leveraging genetic insights and AI-enabled discovery, Halia is building a robust pipeline of novel therapeutics based on genetic resilience that targets inflammatory pathways in diseases ranging from metabolic disorders to neurodegeneration and hematologic malignancies.

- Advertisement -

Halia’s mission is to create data-driven therapies that not only extend life but also improve its quality. The company is headquartered in Lehi, Utah, and is actively advancing global partnerships in clinical research, drug discovery, and personalized medicine.

- Advertisement -

To learn more, visit www.haliatx.com or follow us on LinkedIn and Twitter @HaliaTx.

- Advertisement -

Media Contact

- Advertisement -

Taylor Avei 
Director of Business Development
Halia Therapeutics
info@haliatx.com

- Advertisement -

Investor Contact

- Advertisement -

Leigh Salvo 
New Street Investor Relations
leigh@newstreetir.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/2702932/Halia_Therapeutics_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/halia-therapeutics-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference-302546094.html

- Advertisement -

Recent Posts

Medanta Expands Indore Presence with Takeover of 80 Bed Cancer Hospital

GURUGRAM, India, April 27, 2026 /PRNewswire/ -- Global Health Limited 'Medanta', one of the largest…

33 minutes ago

The EXCEL – First-of-its-kind study highlights critical role of essential phospholipids in improving Fatty Liver Disease

PARIS, April 27, 2026 /PRNewswire/ -- A new study has established that treatment with essential phospholipids…

33 minutes ago

Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia

Phase 2 multicenter, open-label study (NCT07499102) will evaluate the safety and clinical efficacy of CK0801…

33 minutes ago

CONCEPT MEDICAL ANNOUNCES PRELIMINARY 3-YEAR SIRONA DATA AT CHARING CROSS SYMPOSIUM 2026

LONDON, April 27, 2026 /PRNewswire/ -- Concept Medical Inc., today announced the presentation of preliminary…

33 minutes ago

Bombay Founders’ Club Acquires Movement, previously ‘The Indian Startup Community’

The announcement was made at 'The Room' Event in MumbaiMUMBAI, India, April 27, 2026 /PRNewswire/…

4 hours ago

KuCoin Hosts HEXAGON BLOCK PARTY at Hong Kong Web3 Festival, Headlined by DJ Don Diablo and Rooted in Shared Values of Community and Connection

Headlined by internationally renowned DJ Don Diablo, the event brought together guests from the Web3…

4 hours ago